Sotac Pharmaceuticals is in the business of manufacturing pharmaceutical products for different marketers on a loan license or contract manufacturing basis.
| Bidding Dates |
|---|
| 29 Mar 2023 - 03 Apr 2023 |
| Subscription |
|---|
| 1.6x Oversubscribed |
| Minimum Investment | Minimum Lot | Maximum Lot | Lot Size | Number of Shares | Issue Price Band | Post Issue Promoter Holding % | Issue Size | IPO Document |
|---|---|---|---|---|---|---|---|---|
| ₹1,33,200 | 1 | 1 | 1200 | 3.0 M | ₹105 - ₹111 | 72.85 % | ₹315.0 M - ₹333.0 M | RHP DOC |
Sotac Pharma IPO SUBSCRIPTION STATUS
03 Apr '23Sotac Pharma IPO overall subscription rate was 1.6 times the total available shares
Sotac Pharma IPO retail subscription rate was 0.91 times in the retail segment
Sotac Pharma IPO non-institutional investor subscription rate was 4.04 times in the non-institutional investor category
Sotac Pharma IPO Qualified Institutional Bidder subscription rate was 1 times the available shares for Qualified Institutional Bidder
| Day | Retail Individual Investor | HNI (NII) Investors | Qualified Institutional Buyers |
|---|---|---|---|
| Category Reservation | 35% | 15% | 50% |
03 Apr 2023 (Day 3) | 0.91x | 4.04x | 1x |
31 Mar 2023 (Day 2) | 0.15x | 0.72x | 0x |
29 Mar 2023 (Day 1) | 0.02x | 0.05x | 0x |
Sotac Pharma FINANCIALS
| Period | Net Profit (Rs in millions) | Revenue from Operations (Rs in millions) | Cash Flow from Operations (Rs in millions) | Free Cash Flow (Rs in millions) | Margins |
| 9MFY23 | 4.7 | 397.5 | 27.9 | -23.6 | 17.3% |
| FY22 | 28.8 | 731.5 | 63.5 | 28.5 | 8.4% |
| FY21 | -23.7 | 488.4 | -3.1 | -34.7 | 6.4% |
| FY20 | 0.9 | 286.0 | 0.6 | -97.4 | 7.2% |
Sotac Pharma IPO SUBSCRIPTION STATUS DETAILS
Sotac Pharma had 3.0 M shares on offer
Sotac Pharma IPO offer price was in the range ₹105 - ₹111
Sotac Pharma IPO minimum Investment was ₹133200
Sotac Pharma IPO issue size was ₹ 315.0 M - ₹ 333.0 M
Sotac Pharma had a minimum lot size of 1200 Shares per application
Sotac Pharma NUMBER OF SHARES ON OFFER
Sotac Pharma IPO IMPORTANT DATES
| Issue Open Date | 29 Mar 2023 |
| Issue close Date | 03 Apr 2023 |
| Allotment Date | 10 Apr 2023 |
| Refund Date | 11 Apr 2023 |
| Demat Account Credit Date | 12 Apr 2023 |
| Listing Date | 13 Apr 2023 |
| Listing on Exchange(s) | NSE |
| Sotac Pharma Allotment Status | Exchange |
Sotac Pharma IPO subscription opened on 29 Mar 2023, and closed on 03 Apr 2023
IPO allotment for Sotac Pharma was finalized on Monday, 10 Apr 2023
IPO listing for Sotac Pharma was on NSE on Thursday, 13 Apr 2023
Sotac Pharma IPO LISTING GAINS
| Issue Price (adjusted) | 111.0 |
| Listing Open Price | 115.0 |
| Listing Close Price | 120.8 |
| Listing Gain% | 3.6% |
| Current Gain% | -17.2% |
Sotac Pharma Peer
| Stock | Stock Price | Market Cap (Rs crore) | PE TTM | PEG TTM | PS TTM | ROE% | ROA% | Annual Revenue (Rs crore) | Annual Revenue Growth % | Annual Net Profit (Rs crore) | Annual Net Profit Growth % | EPS TTM | EPS TTM Growth % |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sotac Pharmaceuticals Ltd | 92 | 101.6 | 16.1 | -0.7 | 1 | 10.7 | 4.7 | 101.6 | 0.7 | 6.3 | -21.6 | 5.7 | -21.6 |
| Sun Pharmaceutical Industries Ltd. | 1944.4 | 466526.7 | 38.6 | 2.3 | 7.8 | 13.7 | 10.6 | 60433.8 | 10.8 | 11479.4 | 5 | 50.4 | 16.6 |
| Divi's Laboratories Ltd. | 8300 | 220338.9 | 75.3 | 2.8 | 19.6 | 15.3 | 12.8 | 11067 | 14 | 2568 | 17.2 | 110.2 | 26.8 |
| Torrent Pharmaceuticals Ltd. | 4924 | 187293.2 | 85.9 | 9.6 | 11.9 | 25.8 | 4.9 | 13886.2 | 20.3 | 2163.4 | 13.2 | 57.3 | 8.9 |
| Cipla Ltd. | 1467.7 | 118568.6 | 35.2 | -0.9 | 4.2 | 11.3 | 9.1 | 29044.6 | 2.2 | 3879.2 | -26.4 | 41.7 | -37.5 |
| Zydus Lifesciences Ltd. | 1119 | 112597.6 | 22.3 | 2.3 | 4.1 | 18.6 | 9.6 | 27657.9 | 17.6 | 5040 | 11.4 | 50.1 | 9.6 |
Sotac Pharma INFORMATION ON IPO ISSUE
About Sotac Pharma
Sotac Pharmaceuticals is in the business of manufacturing pharmaceutical products for different marketers on a loan license or contract manufacturing basis.
Object of the Issue
- To meet working capital requirements
- Investment in subsidiary
- Upgradation/construction of existing/new buildings on existing premises
- General corporate purpose
- To meet public issue expenses
Sotac Pharma - PROMOTERS
| Name |
|---|
| Sharadkumar Dashrathbhai Patel |
| Dineshkumar Babulal Gelot |
| Vishalkumar Devrajbhai Patel |
| Chetankumar Bachubhai Patel |
| Kiran Baldevbhai Jotania |
Sotac Pharma Lead Manager to the Issue
Beeline Capital Advisors Private Limited
mb@beelinemb.com
Sotac Pharma Registrar to the issue
Kfin Technologies Private Limited
sotac.ipo@kfintech.com
Sotac Pharma Strengths
Wide range of products
The company's existing product portfolio consists of 119 products in total, and 109 of them are non-beta-lactam formulations
Scalable business model
The company's business model is customer-centric, and order-driven. It requires optimum utilisation of existing resources, assuring quality supply and achieving consequent economies of scale
Quality assurance
The company's manufacturing units ensure the highest level of quality assurance. They are WHO-GMP accredited
Sotac Pharma Risks
Certain litigation and claims
The company, promoters, promoter group and group companies are party to certain litigation and claims
Dependent on few customers
The company is dependent on a few customers for sales. Loss of any of these large customers may affect revenues and profitability
Concentrated operations
Its revenues are highly dependent on operations in Gujarat. Any adverse development affecting operations in the region could harm the business
IPO FAQs
The promoters of the company are Sharadkumar Dashrathbhai Patel, Dineshkumar Babulal Gelot, Vishalkumar Devrajbhai Patel, Chetankumar Bachubhai Patel and Kiran Baldevbhai Jotania.
The category allocation of qualified institutional buyers is 50.0%, the category allocation of non individual investors or high networth individuals is 15.0% and for retail investors it is 35.0%.
The price band of the IPO is Rs 105.0 - 111.0.
The IPO application opens on Mar 29, 2023 and closes on Apr 03, 2023.
The minimum lot size for the IPO is 1200. The maximum lot size for the IPO is 1200.
For all category investors, the minimum application amount for this IPO is Rs. 133,200.0, the maximum value for this IPO is Rs 133,200.0.
This IPO will be allotted on Apr 10, 2023.
The refund will be credited to your account on Apr 11, 2023.
The allotted shares will be credited to your demat on Apr 12, 2023.
Sotac Pharmaceuticals Ltd.’s shares listed on the stock exchanges on Apr 13, 2023.